| Authors: |
Knisely A; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Dai Y; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences (GSBS), Houston, Texas., Barlow GL; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts., Lee S; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Lawson B; Department of Anatomical Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Clark H; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Fellman B; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Yuan Y; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Lu W; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Lubo Julio IC; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Lazcano RN; Department of Anatomical Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Chelvanambi M; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Platform for Innovative Microbiome and Translational Research (PRIME-TR), The University of Texas MD Anderson Cancer Center, Houston, Texas., Melendez B; Platform for Innovative Microbiome and Translational Research (PRIME-TR), The University of Texas MD Anderson Cancer Center, Houston, Texas., Singh B; Platform for Innovative Microbiome and Translational Research (PRIME-TR), The University of Texas MD Anderson Cancer Center, Houston, Texas., Singh B; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Wani K; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Chen J; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Yeh CC; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Gao J; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Barnes S; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Shi O; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Khan KB; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Serrano AG; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Gomez-Bolanos LI; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Scalise CB; Natera, Inc., Austin, Texas., Cheung SK; Natera, Inc., Austin, Texas., Dutta P; Natera, Inc., Austin, Texas., Velichko S; Natera, Inc., Austin, Texas., ElNaggar AC; Natera, Inc., Austin, Texas., Liu MC; Natera, Inc., Austin, Texas., Wilke RN; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., How J; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Ramondetta LM; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Boruta DM; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Richardson G; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Shafer A; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Westin SN; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Sims T; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Sood AK; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Ramirez PT; Department of Obstetrics and Gynecology, Neal Cancer Center, Houston Methodist, Houston, Texas., Lazar AJ; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Anatomical Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Soliman PT; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Lu K; Moffitt Cancer Center, Tampa, Florida., Haymaker CL; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Solis Soto LM; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Wargo JA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Platform for Innovative Microbiome and Translational Research (PRIME-TR), The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; The James P. Allison Institute (JPAI), The University of Texas MD Anderson Cancer Center, Houston, Texas., Grisham R; Department of Gynecologic Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Wucherpfennig KW; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts., Wang L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences (GSBS), Houston, Texas.; The James P. Allison Institute (JPAI), The University of Texas MD Anderson Cancer Center, Houston, Texas.; Institute for Data Science in Oncology (IDSO), The University of Texas MD Anderson Cancer Center, Houston, Texas., Jazaeri AA; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. |
